Molecular and Cellular Biology · 2006 · 57 citations · 42 references
Life SciencesCancer BiologyMolecular BiologyChromatin BiologyDna RepairTranscriptional RegulationCancer EpigeneticsChromatinEpigenetic Regulation In CancerHistone ModificationsHistone Post-translational ModificationsHistone ProteinsAcute Promyelocytic LeukemiaChromatin Remodeling After Dna DamageConjugationProtein Subcellular LocalizationSubcellular Protein LocalizationSumoylation In Nucleotide Excision RepairSumoylation In RepairSumoylation-regulated Interactions
Previous studies have demonstrated that the base excision repair enzyme thymine DNA glycosylase (TDG) mediates recruitment of histone acetyltransferases CREB-binding protein (CBP) and p300 to DNA, suggesting a plausible role for these factors in TDG-mediated repair. Furthermore, TDG was found to potentiate CBP/p300-dependent transcription and serve as a substrate for CBP/p300 acetylation. Here, we show that the small ubiquitin-like modifier 1 (SUMO-1) protein binding activity of TDG is essential for activation of CBP and localization to promyelocytic leukemia protein oncogenic domains (PODs). SUMO-1 binding is mediated by two distinct amino- and carboxy-terminal motifs (residues 144 to 148 and 319 to 322) that are negatively regulated by DNA binding via an amino-terminal hydrophilic region (residues 1 to 121). TDG is also posttranslationally modified by covalent conjugation of SUMO-1 (sumoylation) to lysine 341. Interestingly, we found that sumoylation of TDG blocks interaction with CBP and prevents TDG acetylation in vitro. Furthermore, sumoylation effectively abrogates intermolecular SUMO-1 binding and a sumoylation-deficient mutant accumulates in PODs, suggesting that sumoylation negatively regulates translocation to these nuclear structures. These findings suggest that TDG sumoylation promotes intramolecular interactions with amino- and carboxy-terminal SUMO-1 binding motifs that dramatically alter the biochemical properties and subcellular localization of TDG.
42
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Marc S. Greenblatt, W P Bennett, Monica Hollstein et al. · PubMed · 1994 · 3.5K citations
CBP/p300 in cell growth, transformation, and development
Richard H. Goodman, Sarah M. Smolik · Genes & Development · 2000 · 1.8K citations · Full text
The IARC TP53 database: New online mutation analysis and recommendations to users
Magali Olivier, Rosalind A. Eeles, Monica Hollstein et al. · Human Mutation · 2002 · 1.3K citations
PML regulates p53 acetylation and premature senescence induced by oncogenic Ras
Mark Pearson, Roberta Carbone, Carla Sebastiani et al. · Nature · 2000 · 832 citations